| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | $0.1B | $0.1B | $0.1B | $0.1B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.7B | $0.5B | $0.6B | $0.4B | $0.3B | $0.1B | $0.0B | $0.0B |
| EPS (Basic) | $1.80 | $1.69 | $1.95 | $1.51 | $1.68 | $0.45 | $0.29 | $0.28 |
| EPS (Diluted) | $1.79 | $1.68 | $1.94 | $1.50 | $1.67 | $0.44 | $0.29 | $0.28 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $72.2B | $53.6B | $49.1B | $46.8B | $24.5B | $23.0B | $20.4B | $19.7B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $1.8B | $1.2B | $1.2B | $0.7B | $0.8B | $0.6B | $0.3B | $0.3B |
| Total Liabilities | $63.7B | $47.2B | $43.5B | $41.6B | $21.4B | $20.0B | $17.6B | $17.0B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $8.5B | $6.3B | $5.6B | $5.1B | $3.0B | $3.0B | $2.9B | $2.7B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.7B | $0.6B | $0.5B | $0.8B | $0.3B | $0.2B | $0.2B | $0.2B |
| Investing Cash Flow | $-1.8B | $-1.4B | $-1.8B | $-1.7B | $-1.4B | $-2.1B | $-0.5B | $-0.3B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $1.8B | $0.8B | $1.7B | $0.8B | $1.3B | $2.2B | $0.3B | $0.1B |